Although specific functions of SMAP2 in cancer or immune are yet to be known, BioTarget seems to suggest that the altered expression of SMAP2 gene in GATA3 may mediate Th2 differentiation pathway in a cancer type specific manner, that is, through up-regulation in LUSC but through down-regulation in STAD and BRCA. Here, GATA3 is linked to cancer.